Team
We are a team of experts in molecular biology, regulatory management, and clinical development
Leadership
Daniel Dornbusch, MPH MBA
Chief Executive Officer
Revati Shreeniwas, M.D.
Interim Chief Medical Officer
TJ Cradick, Ph.D.
Chief Scientific Officer
Michael Aberman, M.D.
Interim Chief Business Officer
R&D
Jenn Gordon, Ph.D.
VP Preclinical R&D
Previous: Temple University, School of Medicine
Niles Donegan, Ph.D.
Principal Scientist
Previous: Geisel School of Medicine at Dartmouth
Kamel Khalili, Ph.D.
Chief Scientific Founder
Temple University,
School of Medicine
Alexandra Howell, Ph.D.
Research Investigator
Veterans Affairs Medical Center & Geisel School of Medicine at Dartmouth
Rich Stoner, Ph.D.
Bioinformatics Advisor
Former Synthego Gene Sequencing & BioInformatics
Matt Hayden, M.D. Ph.D.
Research Investigator
Dartmouth-Hitchcock Medical Center
Ilker Sariyer, DVM Ph.D.
Research Investigator
Temple University,
School of Medicine
Tricia Burdo, Ph.D.
Preclinical R&D
Temple University,
School of Medicine
Operations
Lucas Buchheim-Jurisson
Chief of Staff
Previous: Rigetti Computing
Amir Khalili
Executive Coordinator
Previous: American Association for Cancer Research
Patricia Williams, Ph.D.
Regulatory Affairs, IND Directions
Previous: Director at BMS, Lilly, Glycomed, Ligand
Ellen Cooper, M.D. MPH
Clinical Affairs, IND Directions
Previous: FDA Antiviral Division, AmFAR
Board of Directors
Daniel Dornbusch, MPH MBA
CEO, Excision
Bill Carson, M.D.
Chairman of the Board, Otsuka Pharmaceutical Development & Commercialization, Inc.
Vasudev Bailey, Ph.D.
Partner, Artis Ventures
Scientific Advisory Board
Keith Jerome, M.D., Ph.D.
Fred Hutchinson Cancer
Research Center
(Herpes Simplex Viruses, Hepatitis B)
John Baxter, M.D.
Cooper University Medical Center
(HIV Clinician)
Robert Bettiker, M.D.
Temple University School of Medicine
(HIV Clinician)
​
Rafik Samuel, M.D.
Temple University School of Medicine
(HIV Clinician)
Joseph Berger, M.D.
Perelman School of Medicine University of Pennsylvania
(JC Virus & PML)
David Thomas, M.D.
Johns Hopkins School of Medicine
(Hepatitis B)
​
David Clifford, M.D.
Washington University School of Medicine in St. Louis
(PML and HIV)
Joseph Bondy-Denomy, Ph.D.
​University of California San Francisco
(CRISPR Inhibitors)
Frank Tufaro, Ph.D.
DNAtrix
(Herpes Simplex Viruses)
John M. Daly, M.D.
Temple University School of Medicine
(Surgeon)
Kenneth L. Tyler, M.D.
University of Colorado Denver – Anschutz Medical Campus
(JC Virus & PML)
Timothy M. Block, Ph.D.
Baruch S. Blumberg Institute
(Hepatitis B)
​
Sam Jackson, M.D.
Alector
(Clinical Trialist)
Mark Kay, Ph.D.
Stanford University
(Viral Delivery)
Mike Walker, Ph.D.
Stanford University
(Bioinformatics)
Linda Law, M.D.
BioHealthConsult
(Regulatory & Clinical Expert)
Business Advisory Board
Annalisa Jenkins, M.B.B.S., F.R.C.P.
Biopharma & Life Sciences Executive
Jeff Kindler
CEO, Centrexion Therapeutics
Michael Marks
Founding Managing Partner, WRVI Capital
Paul Sekhri
President and CEO, eGenesis
​